Optimizing HIV pre-exposure prophylaxis implementation among men who have sex with men in a large urban centre: a dynamic modelling study

INTRODUCTION: Once-daily tenofovir/emtricitabine-based pre-exposure prophylaxis (PrEP) can reduce HIV acquisition in men who have sex with men (MSM), by 44% in the iPrEx trial, and reaching up to 99% with high adherence. We examined the potential population-level impact and cost-effectiveness of dif...

Descripción completa

Detalles Bibliográficos
Autores principales: MacFadden, Derek R, Tan, Darrell H, Mishra, Sharmistha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035769/
https://www.ncbi.nlm.nih.gov/pubmed/27665722
http://dx.doi.org/10.7448/IAS.19.1.20791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035769/
https://www.ncbi.nlm.nih.gov/pubmed/27665722
http://dx.doi.org/10.7448/IAS.19.1.20791

Ejemplares similares